Analysis of the Problems of Listed Biological Products for Therapeutic Use in China and Recommendations for Regulation

Xin Zhongshuai, Zhang Hui, Yang Jianhong, Zhang Yanyan, Shao Ying

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 982-985.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 982-985. DOI: 10.16153/j.1002-7777.2019.09.003

Analysis of the Problems of Listed Biological Products for Therapeutic Use in China and Recommendations for Regulation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(9): 982-985 https://doi.org/10.16153/j.1002-7777.2019.09.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉